If this group of patient have been coded as in remission in the past and have now experienced a new episode you will need to add the Read code for the appropriate mental episode (Example – Schizophrenia, Bipolar or other Psychoses) with either an episode type of ‘New’ or ‘First’, then code the care plan. You require the episode to be read coded with an episode type to supersede the ‘in remission’ Read code.
Q&A
If you are having a problem designing a Mental Health Care plan template you can request an example from Jill Warn.
We recommended a website to help with assessing if a child is obese. I have attached the link http://apps.nccd.cdc.gov/dnpabmi/Calculator.aspx
This should help.
The prescription has to be issued in the preceding 6 months, if you do not issue the medication between 1st October to 31st March it will not count.
V23 Data Set and Business Rules have now been released with a number of amendments. It was recognised that a number of medications had not been included within the therapy QOF clusters, this has been corrected and the medication listed below are now to be included.
fu9..% following:
DENOSUMAB
DENOSUMAB 60mg/1mL solution for injection prefilled syringe
PROLIA 60mg/1mL solution for injection prefilled syringe
XGEVA 120mg/1.7mL solution for injection
DENOSUMAB 120mg/1.7mL solution for injection
fo8..% following:
Ibandronic acid
Ibandronic acd 2mg/2mL i-v inf
Bondronat 1mg/mL inf 2mL amp
Bondronat 50mg tablet
Bondronat 1mg/mL inf 6mL vial
Bonviva 150mg tablet
Bonviva 3mg/3mL inj p/f syrg
Ibandronic acid 3mg/3mL syrg
Ibandronic acid 150mg tablet
Ibandronic acid 6mg/6mL inf
Ibandronic acid 50mg tablet
fn2..% following:
CALCITONIN(SALMON)
*CALSYNAR 100iu/1mL injection
*CALSYNAR 400iu/2mL injection
CALCITONIN(SALM) 50iu/1mL inj
MIACALCIC 50iu/1mL injection
MIACALCIC 100iu/1mL injection
MIACALCIC 400iu/2mL injection
*FORCALTONIN 100iu/1mL inj
MIACALCIC 200iu nasal spray
CALCITONIN(SALMON) 200iu spry
CALCITONIN(SALM) 100iu/1mL inj
CALCITONIN(SALM) 400iu/2mL inj
The Group will need to discuss with the CCG’s representative to agree which care pathways will be followed this year. For QP1 – QP3 the guidance suggests you may wish to look more closely at existing care pathways. The guidance outlined in QP1-3 applies to QP4 – QP9. If the care pathways from the previous year has not helped to maintain or improved areas for the referrals, emergency admissions and A&E avoidance, we would recommend you identify new care pathways.
We would recommend practices Read Code their A&E attendances, admissions, EAU referrals and frequent attenders, this will enable you to compare data received from the PCT. Below are the suggested codes.
CTV3– SystmOne
XaQsi Referral to acute medical assessment unit
XaKNv Seen in out of hours centre
XaN0k Seen in walk in centre
XaAL0 Admission by accident and emergency doctor
XaQW2 Self-referral to accident and emergency department
XaZ7j Frequent attender of accident and emergency department
Version 2 – EMIS, Vision, Torex and Microtest
8HlH. Referral to acute medical assessment unit
9N0l. Seen in out of hours centre
9N0x. Seen in walk in centre
8Hd1. Admission by accident and emergency doctor
8HJJ. Self-referral to accident and emergency department
13Zz. Frequent attender of accident and emergency department
The three care pathways cannot be the same for QP6-8 and QP9-11
QP11, more guidance related to this area can be found on page169 in the Quality and Outcomes Framework guidance for GMS contract 2011/12.
It is important these patients receive a review by the practice as they are new in the area and the review is about their wellbeing, patient’s individual health, support needs and the coordination between the sectors. It is not appropriate to move the diagnosis date either so I would suggest you ensure they have a review but for the purpose of the QOF if they do prevent you from achieving at the end of the QOF year then you exception report them with an explanation as to why. You may even wish to add the date the review has taken place in the free text to evidence you have cared for the patient as expected.
There is no age criteria for the Asthma register, if they have a diagnosis in their record and they have been prescribed inhalers they will appear in ‘work to do’. It is not appropriate to exclude children 8 years and under from the review indicator. If the child is not able to give an answer to the three RCP questions, these should be directed at the guardian attending with the child.
Children will not appear in Asthma 002 ‘confirmation of diagnosis’ until the year of their 8th birthday.